References
- Ayhanci, A., Uyar, R., Aral, E., Kabader, S., Appak, S. (2008). Protective effect of zinc on cyclophosphamide-induced hematoxicity and urotoxicity. Biol Trace Elem Res 126:186–193.
- Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., Selby, P. B. (1995). Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risk. Mutat Res 330:115–181.
- Bergsagel, D. E., Roberson, G. L., Hasselback, R. (1968). Effect of cyclophosphamide on advanced lung cancer and haematological toxicity of large, intermittent intravenous doses. Can Med Assoc J 98:532–538.
- Cao, S., Durrani, F. A., Rustum, Y. M. (2004). Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10:2561–2569.
- Fraiser, L. H., Kanekal, S., Kehrer, J. P. (1991). Cyclophosphamide toxicity: characterizing and avoiding the problem. Drugs 42:781–795.
- George, K. S., Rajesh, R., Sunil Kumar, S., Sulekha, B., Balaram, P., (2008). A polyherbal ayurvedic drug—Indukantha Ghritham as an adjuvant to cancer chemotherapy via immunomodulation. Immunobiology 213:641–649.
- Hoffmann, P. R., Berry, M. J. (2008). The influence of selenium on immune responses. Mol Nutr Res 52:1273–1280.
- Jamba, L., Nehru, B., Bansal, M. P. (1997). Selenium supplementation during cadmium exposure: changes in antioxidant enzymes and the ultrastructure of the kidney. J Trace Elements Exp Med 10:233–242.
- Kumar, K. B. H., Kuttan, R (2005). Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide-induced toxicity in mice Phytomedicine 12:494–500.
- Kumari, J., Shaoo, P. K. (2005). Effects of cyclophosphamide on the immune system and disease resistance of Asian catfish Clarias batrachus. Fish Shellfish Immunol 19:307–316.
- Langford, C. A. (1997). Complications of cyclophosphamide therapy. Eur Arch Otorhinolaringol 254:65–72.
- Liang, J., Huang, M., Duan, W., Yu, X-Q., Zhou, S. (2007). Design of new oxazaphosphorine anticancer drugs. Curr Pharm Des 13:963–978.
- Manda, K., Bhatia, A. L. (2003). Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19:367–372.
- Nomura, A. M. Y., Lee, J., Stemmermann, G. N., Combs, G. F. (2000). Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887.
- Olas, B., Wachowicz, B. (1997). Selenium in the cytotoxicity of cisplatin. Postepy Hyg Med Dos 51:95–108.
- Schuurman, H. J., Smith, H. T., Cozzi, E. (2005). Tolerability of cyclophosphamide and methotrexate induction immunosuppression in nonhuman primates. Toxicology 213:1–12.
- Selvakumar, E., Prahalathan, C., Sudharsan, P. T., Varalakshmi, P. (2006). Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm. Toxicology 217:71–78.
- Shah, A. S., Wakade, A. S., Juvekar, A. R. (2008). Immunomodulatory activity of methanolic extract of Murraya koenigii (L) Spreng leaves. Ind J Exp Biol 46 (7): 505–509.
- Sieja, K., Talerczyk, M. (2004). Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 93:320–327.
- Spallholz, J. E. (2003). Use of selenium to prevent and treat cancer in the new millennium. J Kor Assoc Cancer Prev 8:9–23.
- Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., et al. (2004). Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer 40:1713–1723.
- Zeng, H., Combs, J. G. F. (2008). Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19:1–7.